|

Immune Globulin Intravenous Clinical Trials

3 actively recruiting trials

Also known as: IVIG, Immune Globulin Subcutaneous

Pipeline

Phase 2/3: 3

Top Sponsors

  • Monash University3

Indications

  • Non Hodgkin's Lymphoma3
  • Myeloma3
  • Leukemia3
  • Cancer3

Other3 trials

Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Dosing Immunoglobulin (Dose Ig)
Phase 2/3
Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Immunoglobulin Stopping or Extension (Stop Ig)
Phase 2/3
Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Starting Immunoglobulin (Start Ig)
Phase 2/3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.